| BeiGene Switzerland GmbH - Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung |
| 68960 | | 01 | | Tevimbra, 100 mg / 10 ml Konzentrat zur Herstellung einer Infusionslösung | | | | L01FF09 | | | | 11.04.2024 | | |
|
| Composition |
| tislelizumabum 100 mg, natrii citras dihydricus, acidum citricum monohydricum, histidini hydrochloridum monohydricum, histidinum, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 16 mg. |
| Packungsbestandteile |
| | | | | | Principe actif | Concentr. |
|---|
| Tislelizumabum | 100mg / 10ml |
| | BAG: Principe actif | Concentr. |
|---|
| Tislelizumabum | 100 mg |
| | | | Agents auxilliaires |
|---|
| Acide Citrique Monohydre | | Histidin Hydrochloride Monohydrate | | Histidine | | Natrii Citras Dihydricus | | Polysorbatum 20 | | Trehalosum Dihydricum |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 1816.16 | 1991.60 | A | LS | Non |
|
